Medication strategies in childhood aggression: A review

Canadian Journal of Psychiatry

Volumn 48, Issue 6, 2003, Pages 367-373

  Bassarath, Lindley ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Aggression; Child psychiatric disorder; Evidence based practice; Psychopharmacology

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMIPRAMINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; GUANFACINE; HALOPERIDOL; LITHIUM; METHYLPHENIDATE; MOLINDONE; NADOLOL; NEUROLEPTIC AGENT; PROPRANOLOL; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; THIORIDAZINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

AGGRESSION; ATAXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER PROGRAM; CONDUCT DISORDER; DIARRHEA; DRUG BLOOD LEVEL; DRUG EFFICACY; ENURESIS; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HEADACHE; HUMAN; HYPOTHYROIDISM; LIVER TOXICITY; MOOD DISORDER; NAUSEA; POLYURIA; PSYCHOPHARMACOTHERAPY; REVIEW; SEDATION; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING; WEIGHT GAIN;

EID: 0041925124     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370304800602     Document Type: Review

References (64)

1. Bassarath L. Conduct disorder: a biopsychosocial review. Can J Psychiatry 2001;46:609-16.
2. Kazdin AE. Conduct disorder in childhood and adolescence. 2nd ed. Thousand Oaks (CA): Sage; 1995.
3. Frick PJ. Effective interventions for children and adolescents with conduct disorder. Can J Psychiatry 2001;46:597-608.
4. Connor DF, Steingard RJ. A clinical approach to the pharmacotherapy of aggression in children and adolescents. Ann N Y Acad Sci 1996;794:290-307.
5. Kazdin AE. Treatment of antisocial behaviour in children and adolescents. Homewood (IL): Dorsey; 1985.
6. Offord DR, Boyle MH, Fleming JE, Munroe Blum H, Rae-Grant NI. Ontario Child Health Study: summary of selected results. Can J Psychiatry 1989;34:483-91.
7. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
8. Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, and Blumer JL. A double-blind pilot study of risperidone in treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 2000;39:4:509-16.
9. Buitelaar JK. Open-label treatment with risperidone of 26 psychiatrically hospitalized children and adolescents with mixed diagnoses and aggressive behavior. J Child Adolesc Psychopharmacol 2000;10:19-26.
10. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG, and others. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 1984;41:650-6.
11. Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 2000;57:649-54.
12. Rifkin A, Karajgi B, Dicker R, Perl E, Boppana V, Hasan N, and others. Lithium treatment of conduct disorders in adolescents. Am J Psychiatry 1997;154:554-5.
13. Klein RG. Preliminary results: lithium effects in conduct disorders. CME Syllabus and Proceedings Summary, Symposium 2. The 144th Annual Meeting of the American Psychiatric Association; 1991 May 11-16; New Orleans (LA). Washington (DC): American Psychiatric Association. p. 119-120.
14. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull 1992;28:193-9.
15. Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1996;35:480-90.
16. Donovan SJ, Stewart JW, Nunes EV, Stewart JW, Quitkin FM, Parides M. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 2000;157:818-20.
17. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 1990;29:710-8.
18. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 1997;54:1073-80.
19. Campbell M, Gonzalez NM, Silva RR. The pharmacologic treatment of conduct disorders and rage outbursts. Psychiatr Clin North Am 1992;15:69-85.
20. Kemph JP, DeVane CL, Levin GM, Jarecke R, Miller RL. Treatment of aggressive children with clonidine: results of an open pilot study. J Am Acad Child Adolesc Psychiatry 1993;32:577-81.
21. Petti TA, Fish B, Shapiro T, Cohen IL, Campbell M. Effects of chlordiazepoxide in disturbed children: a pilot study. J Clin Psychopharmacol 1982;2:270-3.
22. Zubieta JK, Alessi NE. Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children. J Clin Psychopharmacol 1992;12:346-51.
23. Frick PJ. Effective interventions for children and adolescents with conduct disorder. Can J Psychiatry 2001;46:597-608.
24. Offord DR, Boyle MH, Racine YA. The epidemiology of antisocial behavior in childhood and adolescence. In: Pepler DJ, Rubin KH, editors. The development and treatment of childhood aggression Hillsdale (NJ): Lawrence Erlbaum; 1991. p 21-54.
25. Biederman J, Faraone SV, Lapey K. Child and Adolescent Psychiatric Clinics of North America 1992;1:335-60.
26. Barkley RA. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 2nd ed. New York: Guilford Press; 1998.
27. Hinshaw SP, Henker B, Whalen CK. Self-control in hyperactive boys in anger-inducing situations: effects of cognitive-behavioral training and of methylphenidate. J Abnorm Child Psychol 1984;12:155-77.
28. Matier K, Halperin JM, Sharma V, Newcorn JH, Sathaye N. Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms. J Am Acad Child Adolesc Psychiatry 1992;31:219-25.
29. Winsberg BG, Press M, Bialer I, Kupietz S. Dextroamphetamine and methylphenidate in the treatment of hyperactive-aggressive children. Pediatrics 1974;53:236-41.
30. Amery B, Minichiello MD, Brown GL. Aggression in hyperactive boys: response to D-amphetamine. J Am Acad Child Psychiatry 1984;23:291-4.
31. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 1985;24:617-29.
32. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr 2000;39:15-25.
33. Hunt RD, Amsten AF, Asbell MD. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:50-4.
34. Clay TH, Gualtieri CT, Evans RW, Gullion CM. Clinical and neuropsychological effects of the novel antidepressant bupropion. Psychopharmacol Bull 1988;24:143-8.
35. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS. A double-blind placebo controlled study of desipramine in the treatment of ADD: 1. Efficacy. J Am Acad Child Adolesc Psychiatry 1989;28:777-84.
36. Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol 1996;6:165-75.
37. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M. Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 1991;30:762-7.
38. Olvera RL, Pliszka SR, Luh J, Tatum R. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol 1996;6:241-50.
39. Pine DS, Klein RG, Lindy DC, Marshall RD. Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations. J Clin Psychiatry 1993;54:140-5.
40. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34:454-63.
41. Carlson GA. Clinical features and pathogenesis of child and adolescent mania. In: Shulman KI, Tohen M, Kutcher SP, editors. Mood disorders across the life span. New York: Wiley-Liss; 1996. p. 127-47.
42. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J, Williams M, and others. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-8.
43. Weller EB, Weller RA, Fristad MA. Lithium dosage guide for prepubertal children: a preliminary report. J Am Acad Child Psychiatry 1986;25:92-5.
44. Sadock BJ, Kaplan VA. Pocket handbook of clinical psychiatry. 3rd ed.. Philadelphia: Lippincott Williams and Wilkins; 2001. p 275-305.
45. Deltito JA, Levitan J, Damore J, Hajal F, Zambenedetti M. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients. Acta Psychiatr Scand 1998;973:236-40.
46. West SA, Keck PE, McElroy SL, Strakowski SM, Minnery KL, McConcille BJ, and others. Open trial of valproate in the treatment of adolescent mania. J Child Adolesc Psychopharmacol 1994;4:263-7.
47. Kutcher SP. Affective disorders in children and adolescents: a critical clinically relevant review. In: Walsh BT, editor, Child psychopharmacology. American Psychiatric Association Review of Psychiatry. Volume 17. Washington (DC); APA; 1998. p 91-114.
48. Frazier JA, Meyer MC, Biederman J, Wozniak J, Wilens TE, Spencer TJ, and others. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999;38:960-5.
49. Scheier HA. Risperidone for young children with mood disorders and aggressive behaviour. J Child Adolesc Psychopharmacol 1998;8:49-59.
50. Angold A, Costello EJ. Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. Am J Psychiatry 1993;150:1779-91.
51. Kashani JH, Dahlmeier JM, Borduin CM, Soltys S, Reid JC. Characteristics of anger expression in depressed children. J Am Acad Child Adolesc Psychiatry 1995;34:322-6.
52. Treuting JJ, Hinshaw SP. Depression and self-esteem in boys with attention-deficit/hyperactivity disorder: associations with comorbid aggression and explanatory attributional mechanisms. J Abnorm Child Psychol 2001;29:23-39.
53. Constantino JN, Liberman M, Kincaid M. Effects of serotonin reuptake inhibitors on aggressive behaviour in psychiatrically hospitalized adolescents: results of an open trial. J Child Adolesc Psychopharmacol 1997;7:31-44.
54. Zubieta JK, Alessi NE. Acute and chronic administration of trazodone in the treatment of disruptive behaviour disorders in children. J Clin Psychopharmacol 1992:12:346-51.
55. Pfeffer Cr, Jiang H, Domeshek LJ. Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. J Child Adolesc Psychopharmacol 1997;7:145-55.
56. Lewis DO, Lovely R, Yeager C, Della Femina D. Toward a theory of the genesis of violence: a follow-up study of delinquents. J Am Acad Child Adolesc Psychiatry 1989;28:431-6.
57. Allan ER, Alpert M, Sison CE, Citrome L, Laury G, Berman I. Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients. J Clin Psychiatry 1996;57:455-9.
58. Williams DT, Mehl R, Yudofsky S, Adams D, Roseman B. The effect of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. J Am Acad Child Psychiatry 1982;21:129-35.
59. Famularo R, Kinscherff R, Fenton T. Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child 1988;142:1244-7.
60. Van Bellinghen M, De Troch C. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 2001;11:5-13.
61. Sandor P, Stephens RJ. Risperidone treatment of aggressive behaviour in children with Tourette syndrome [[etter]. J. Clin Psychopharmacol 2000;20:710-2.
62. Anderson LT, Campbell M, Adams P, Small AM, Perry R, Shell J. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children. J Autism Dev Disord 1989;19:227-39.
63. Joshi PT, Capozzoli JA, Coyle JT. Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder. Am J Psychiatry 1988;145:335-8.
64. Gordon CT, State RC, Nelson J, Hamburger SD, Rapoport JL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993;50:441-7.